BANGKOK (AP) — Health authorities in Thailand began their much-anticipated mass rollout of locally produced AstraZeneca vaccines yesterday, but it appeared that supplies were falling short of demand from patients who had scheduled vaccinations for
Hospitals in various parts of the country have been posting notices for several days that some scheduled appointments would be delayed, adding to existing public scepticism about how many doses Siam Bioscience would be able to produce each month.
The government has said it will produce six million doses in June, then 10 million doses each month from July to November, and five million doses in December.
“The vaccines will be delivered as planned,” Prime Minister Prayuth Chan-ocha told reporters yesterday as he paid a visit to a vaccination station at an indoor stadium in the capital, Bangkok.
Prayuth’s government has come under fierce criticism for failure to secure timely and sufficient vaccine supplies. It also faces criticism for its reliance on Siam Bioscience, which is owned by the country’s king and had no previous experience in vaccine production. Prayuth said the Health Ministry had confirmed that vaccinations could begin in every province, and vaccines would be allocated according to the infection rate in each area.